Talphera (TLPH) Competitors $0.60 -0.01 (-1.88%) Closing price 02/21/2025 03:56 PM EasternExtended Trading$0.64 +0.04 (+7.41%) As of 02/21/2025 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TLPH vs. OSTX, BRNS, ESLA, ATHE, RAPT, INKT, QTTB, ANVS, TPST, and CASIShould you be buying Talphera stock or one of its competitors? The main competitors of Talphera include OS Therapies (OSTX), Barinthus Biotherapeutics (BRNS), Estrella Immunopharma (ESLA), Alterity Therapeutics (ATHE), RAPT Therapeutics (RAPT), MiNK Therapeutics (INKT), Q32 Bio (QTTB), Annovis Bio (ANVS), Tempest Therapeutics (TPST), and CASI Pharmaceuticals (CASI). These companies are all part of the "pharmaceutical products" industry. Talphera vs. OS Therapies Barinthus Biotherapeutics Estrella Immunopharma Alterity Therapeutics RAPT Therapeutics MiNK Therapeutics Q32 Bio Annovis Bio Tempest Therapeutics CASI Pharmaceuticals OS Therapies (NYSE:OSTX) and Talphera (NASDAQ:TLPH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, community ranking, risk, analyst recommendations, earnings, dividends and profitability. Do analysts recommend OSTX or TLPH? OS Therapies presently has a consensus price target of $17.50, indicating a potential upside of 929.41%. Talphera has a consensus price target of $4.33, indicating a potential upside of 621.62%. Given OS Therapies' higher probable upside, equities research analysts clearly believe OS Therapies is more favorable than Talphera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OS Therapies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Talphera 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 Which has stronger valuation & earnings, OSTX or TLPH? OS Therapies has higher earnings, but lower revenue than Talphera. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOS TherapiesN/AN/A-$7.79MN/AN/ATalphera$650K15.73-$18.40M-$0.69-0.87 Is OSTX or TLPH more profitable? OS Therapies' return on equity of 0.00% beat Talphera's return on equity.Company Net Margins Return on Equity Return on Assets OS TherapiesN/A N/A -569.57% Talphera N/A -118.46%-65.82% Does the MarketBeat Community prefer OSTX or TLPH? Talphera received 2 more outperform votes than OS Therapies when rated by MarketBeat users. CompanyUnderperformOutperformOS TherapiesOutperform Votes7100.00% Underperform VotesNo VotesTalpheraOutperform Votes9100.00% Underperform VotesNo Votes Do institutionals and insiders believe in OSTX or TLPH? 37.7% of Talphera shares are owned by institutional investors. 3.2% of Talphera shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to OSTX or TLPH? In the previous week, OS Therapies had 6 more articles in the media than Talphera. MarketBeat recorded 6 mentions for OS Therapies and 0 mentions for Talphera. OS Therapies' average media sentiment score of 0.11 beat Talphera's score of 0.00 indicating that OS Therapies is being referred to more favorably in the media. Company Overall Sentiment OS Therapies Neutral Talphera Neutral SummaryOS Therapies and Talphera tied by winning 5 of the 10 factors compared between the two stocks. Get Talphera News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLPH vs. The Competition Export to ExcelMetricTalpheraPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.23M$7.04B$5.77B$8.98BDividend YieldN/A2.87%4.78%3.85%P/E Ratio-0.876.1326.4618.82Price / Sales15.73312.72448.1776.45Price / CashN/A67.8344.0437.47Price / Book0.726.747.634.64Net Income-$18.40M$138.11M$3.18B$245.69M7 Day Performance-7.33%-2.02%-1.82%-2.63%1 Month Performance-4.71%-1.54%0.22%-2.37%1 Year Performance-50.78%-3.14%17.49%13.65% Talphera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLPHTalphera2.566 of 5 stars$0.60-1.9%$4.33+621.6%-50.8%$10.23M$650,000.00-0.8719OSTXOS Therapies2.4659 of 5 stars$1.90-3.1%$17.50+821.1%N/A$41.66MN/A0.00N/AAnalyst ForecastInsider TradeNews CoverageGap DownBRNSBarinthus Biotherapeutics2.8043 of 5 stars$1.01-1.9%$5.17+411.6%-61.5%$40.63M$800,000.00-0.68107Gap DownESLAEstrella Immunopharma2.7645 of 5 stars$1.07-4.5%N/A+42.3%$40.52MN/A-4.12N/AAnalyst ForecastNews CoverageGap UpATHEAlterity Therapeutics1.3585 of 5 stars$4.62+8.7%$8.00+73.2%+100.0%$40.38MN/A0.0010Gap UpRAPTRAPT Therapeutics4.1947 of 5 stars$1.15-0.9%$9.56+730.9%-87.7%$40.20M$1.53M-0.4280Gap UpINKTMiNK Therapeutics2.4757 of 5 stars$9.96-11.0%$65.00+552.6%+10.7%$39.44MN/A-2.5530News CoverageQTTBQ32 Bio2.9948 of 5 stars$3.18+1.0%$29.86+838.9%N/A$38.73M$1.16M-0.2239ANVSAnnovis Bio2.1071 of 5 stars$2.71-7.7%$31.40+1,057.0%-79.0%$38.65MN/A-0.613TPSTTempest Therapeutics2.7667 of 5 stars$0.88+0.3%$21.67+2,364.1%-76.4%$38.37MN/A-0.5720High Trading VolumeCASICASI Pharmaceuticals3.7255 of 5 stars$2.47+0.4%$6.00+142.9%-55.4%$38.26M$33.88M-1.11180Gap Up Related Companies and Tools Related Companies OS Therapies Alternatives Barinthus Biotherapeutics Alternatives Estrella Immunopharma Alternatives Alterity Therapeutics Alternatives RAPT Therapeutics Alternatives MiNK Therapeutics Alternatives Q32 Bio Alternatives Annovis Bio Alternatives Tempest Therapeutics Alternatives CASI Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLPH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLPH Stock Alerts